NCT06381206View on ClinicalTrials.gov

Silodosin in Management of Lower Ureteral Stones

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 20, 2022

Primary Completion Date

October 20, 2023

Study Completion Date

October 25, 2023

Conditions
Stone, Kidney
Interventions
DRUG

Silodosin

Selective Alpha Blocker drug

Trial Locations (1)

1

Damascus university, Damascus

All Listed Sponsors
lead

Syrian Private University

OTHER